Commentary · 8 Apr 2026
Conference abstractPublished 26 Nov 2012
Evaluation of tacrolimus effect on ROS and total antioxidant status in beta cell lines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A fter organ transplantation, an immunosuppressive drug FK506 (tacrolimus) which interrupts Ca-calmodulin?calcineurin signaling pathways in T lymphocytes by blocking antigen activation of T cell early activation genes, will be used. Among its side effects, tacrolimus can cause insulin-requiring diabetes mellitus during clinical use. In fact, it increases the risk of post- transplant diabetes (PTDM). The incidence of insulin-dependent PTDM was significantly higher among tacrolimus-treated patients than among cyclosporine-treated patients (9.8% vs. 2.7%). The purpose of this study was to evaluate the effects of FK506 on human beta cells. We measured the antioxidant status and reactive oxygen species (ROS) levels after tacrolimus treatment. The production of ROS was determined by the flow cytometry. Total antioxidant status (TAS) was measured using TAS kits. Tacrolimus resulted in dose- and time-dependent increases in the production of ROS by beta cells. The antioxidant status decreased in the beta cells after tacrolimus treatment. Increased production of ROS species and decreased antioxidant status by tacrolimus in beta cells may contribute to its side effects.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Toxicology.
Perspective · 25 Feb 2026
Toxicological and Health Effects: Mechanisms, Exposure Routes and Prevention Strategies
Case report · 23 Feb 2026
Case Report: Methaemoglobinaemia Following Indoxacarb Ingestion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Toxicology
- SubjectToxicology
- BylineArticles whose byline prints “Fatemeh Namvaran”
